ZeroFOX Acquires Cyveillance, Strengthening Global Leadership in Digital Risk Protection
6.10.2020 16:00:00 EEST | Business Wire | Press release
ZeroFOX, the global leader in Digital Risk Protection, is proud to announce the acquisition of the Cyveillance business from LookingGlass Cyber Solutions, Inc™. The Cyveillance team has over 20 years of experience delivering comprehensive threat intelligence services, protecting the corporate brands, executives, and data of the world's largest and most respected financial services, energy, and public sector organizations. The combination of the ZeroFOX Artificial Intelligence-powered Digital Risk Protection Platform with Cyveillance’s comprehensive threat intelligence data lake and expansive human dark web intelligence capabilities positions ZeroFOX as the world leader in Digital Risk Protection, connecting automated protection and intelligence for organizations of all sizes.
“Our merger with the Cyveillance team fulfills our strategic vision of accelerating our position as the definitive worldwide leader in Digital Risk Protection,” said James C. Foster, CEO of ZeroFOX. “The addition of Cyveillance allows us to further scale our Digital Risk Protection services and expand our threat intelligence capabilities, complementing our renowned AI & remediation capabilities, to address the entire digital threat lifecycle. Our combined customer base and over 400 employees makes us the largest, most proven provider in the Digital Risk Protection market, serving the needs of the world’s most recognized brands.”
Organizations today operate in a world that demands a digital-first approach. The dramatic shift creates a global digital footprint and attack surface on social media, mobile applications, websites, and other external digital platforms. This unprotected public attack surface exposes organizations and their communities to targeted cyber-attacks, data loss, phishing scams, compliance violations, and account takeovers.
“ZeroFOX’s cyber platform powered by Artificial intelligence and Machine Learning is truly impressive. It was clear that we needed to bring these two organizations together to achieve scale overnight to benefit our customers,” said Gilman Louie, co-founder of Alsop Louie and Executive Chairman of LookingGlass Cyber Solutions. “Combined with the rich Cyveillance data, human and machine intelligence and expertise, our customers will now be fully equipped to combat growing digital threats and exert security control back into digital experiences. This new powerhouse company will enable customers to achieve a new level of protection that is unique in the industry. Foster has built a world-class team and I am excited to join it and the ZeroFOX Board of Directors.” Louie serves as the commissioner for the United States National Security Commission for Artificial Intelligence and Chairman of the Federation of American Scientists.
While the scale of threats targeting public platforms makes it difficult for security teams to create actionable intelligence and seek timely remediation, the combined power of the ZeroFOX Digital Risk Protection Platform and Cyveillance’s customer-centric Digital Risk Protection services will give customers unparalleled visibility, analysis, and remediation capabilities to prioritize and mitigate threats at internet scale and speed.
“Since 2005, I have been honored to be a member of the Cyveillance team. With decades of threat intelligence tradecraft experience and a state of the art 24x7 Cyber Security Center, Cyveillance brings a best-in-class data collection and vetting advantage over all other TI providers. This enriched Intelligence delivered within the ZeroFOX Platform will enable customers to achieve a new level of protection that is years ahead of the competition,” said James Carnall, Cyveillance General Manager. “I look forward to partnering with ZeroFOX to deliver timely, relevant and actionable threat intelligence. It’s clear that we will have the most robust Digital Risk Protection and Threat Intelligence portfolio available in the market.”
ZeroFOX will expand its service offerings for existing customers by leveraging the Cyveillance team, technology and their extensive collection of intelligence data. Existing Cyveillance customers will continue to receive custom Digital Risk Protection services and have access to the power of the ZeroFOX Digital Risk Protection Platform and its industry-leading remediation services.
Cyveillance capabilities include:
- Cyveillance Digital Risk Protection Services - A customer-centric Digital Risk Protection managed service that augments the force of information security teams looking to identify, analyze, and disrupt threats to critical assets and data.
- Cyveillance Data Lake - Cyveillance has the world's largest repository of cyber threat intelligence and threat actor information with more than 20 years of data assembled from the surface, deep, and dark web—powering enrichment, contextualization, API feeds, and threat hunting.
- Cyveillance Finished Intelligence - A digital library of actionable and relevant finished intelligence based on primary threat research and a proprietary intelligence data lake.
- Cyveillance Investigation, Analysis and Response Services - Custom investigation and analysis for physical and digital threats. Advanced analysts provide deep-dive reports, security forensics, threat assessments, research projects, and ad-hoc analyst projects. Projects are designed to dynamically apply and incorporate industry best practices into security and risk management programs.
As part of the acquisition, ZeroFOX will continue to exhibit leadership in this new cybersecurity era by establishing a world-class Cybersecurity Center of Excellence in the Washington, D.C., Metro Area with major offices in Reston, Virginia, and Baltimore, Maryland. This includes a state-of-the-art Cybersecurity Operations Center and Executive Briefing facility for demonstrating and leading organizations on cybersecurity trends, best practices, and technology innovations for Digital Risk Protection. ZeroFOX will also continue to grow its Centers of Excellence in the United Kingdom, Latin America, Asia and the Middle East with a focus on security operations and R&D.
ZeroFOX is trusted by global enterprises, serving thousands of customers, including more than 350 financial institutions in every major country. Funding by Intel Capital, NEA, Highland Capital Partners, Redline Capital Management, Hercules Capital, Comcast Ventures, and Core Capital, ZeroFOX has raised over $150 million in funding to date.
About ZeroFOX - ZeroFOX, the global category leader in Digital Risk Protection, safeguards modern organizations from dynamic security risks across the public attack surface including social media, mobile application, surface, deep and dark web, email and domains, and digital collaboration platforms. With complete global coverage and an artificial intelligence-based analysis engine, the ZeroFOX Platform identifies and remediates targeted phishing attacks, credential compromise, data exfiltration, brand hijacking, executive and location threats, and more. The patented ZeroFOX Platform technology processes and protects millions of posts, messages, and accounts daily across the social and digital landscape, spanning LinkedIn, Facebook, Slack, Instagram, Pastebin, YouTube, mobile app stores, domains, cloud-based email, and more.
About Cyveillance - Cyveillance, which was acquired by LookingGlass in 2015, has a rich history of providing customer-centric threat intelligence services to protect the most critical assets of enterprises worldwide. Founded in 1997, Cyveillance delivers an open source intelligence-led approach to security through continuous, comprehensive monitoring and analysis of millions of online data sources to protect client information, infrastructure, and employees from physical and online threats.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005690/en/
Contact information
PAN Communications
Alexandra Evans
ZeroFOX@pancomm.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
